Copyright
©The Author(s) 2016.
World J Hepatol. Jun 18, 2016; 8(17): 726-730
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.726
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.726
Figure 1 Relative levels of serum levels (A) and liver mRNA (B) of α-2-macroglobulin.
Changes in serum levels (μg/mL) (A) and liver mRNA (% of controls) (B) of α-2-macroglobulin (α-2-M) in controls (n = 8) and in animals injected with LPS 24 h after vehicle (n = 8), anti-CD163mAb-dexa (n = 8), high dose (n = 8) and low dose (n = 8) dexamethasone. mRNA results from LPS-injected animals are presented as relative levels compared to control animals. Bars represent the mean and SEM. aP < 0.05 vs controls. LPS: Lipopolysaccharide; SEM: Standard error of mean.
- Citation: Thomsen KL, Møller HJ, Graversen JH, Magnusson NE, Moestrup SK, Vilstrup H, Grønbæk H. Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats. World J Hepatol 2016; 8(17): 726-730
- URL: https://www.wjgnet.com/1948-5182/full/v8/i17/726.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i17.726